Clinical Trials Logo

Clinical Trial Summary

18F-fluoride is a positron-emitting bone-seeking agent with favorable pharmacokinetic properties. Its uptake mechanism resembles that of 99mTc-MDP. After IV administration, 18F-fluoride diffuses through the bone capillaries into the bone extracellular fluid (ECF). Its plasma clearance is more rapid than that of 99mTc-MDP and its single-passage extraction efficiency is higher. The fast blood clearance of 18F-fluoride results in a better target- to- background ratio. Bone uptake of 18F-fluoride is two-fold higher than that of 99mTc-MDP. Combining the favorable pharmacokinetic characteristics of 18F-fluoride with the high performance of PET technology, 18F-fluoride is a valuable imaging modality of the skeleton.

There are only few manuscripts on the role of static 18F-fluoride PET for detection of lesions in patients referred for non-oncologic indications The purpose of the study is to prospectively assess the added value of Fluoride PET/CT in the clinical setting of acute knee injury. The findings of Fluoride PET/CT will be correlated with those found on arthroscopy and MRI which the currently used diagnostic techniques with a high, however, not perfect diagnostic accuracy regarding the issue of bone injury which is a critical component on the long term outcome after knee injury.


Clinical Trial Description

We intend to inject only 5mCi of Fluoride, as we already did before, thus reducing the radiation exposure to half of that of the routine Tc-MDP bone scintigraphy.

We will refer 50 patients over the age of 18 who had knee trauma, intent to or had MRI assessment and are scheduled for arthroscopy. The compartments of the injured knee will be evaluated on each of the modalities.

Exclusion criterion is pregnancy ;


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00687921
Study type Observational
Source Tel-Aviv Sourasky Medical Center
Contact Einat Even-sapir, PhD, MD
Phone 972-3-697-3432
Email evensap@tasmc.health.gov.il
Status Not yet recruiting
Phase N/A
Start date June 2008
Completion date June 2009

See also
  Status Clinical Trial Phase
Completed NCT02649322 - Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy N/A
Terminated NCT00793104 - Evaluation of the CR Plug (Allograft) for the Treatment of a Cartilage Injury in the Knee. Phase 3
Completed NCT02065518 - Electromyostimulation and Strength Walking for Knee Injuries N/A
Terminated NCT01382173 - Monitoring Of Helsingborg Acute Knee Injuries (MOHAK)
Completed NCT00332254 - Study to Prevent Cartilage Damage Following Acute Knee Injury. Phase 1/Phase 2
Completed NCT01971645 - Decadron as Adjuvant in Femoral Nerve Blocks in Knee Arthroscopy Phase 3
Completed NCT02637505 - Norwegian Cartilage Project - Microfracture N/A
Completed NCT02148172 - Optimizing Plyometric Training for Functional Recovery Post-ACL Reconstruction N/A
Terminated NCT00984594 - Evaluation of a Composite Cancellous and Demineralized Bone Plug (CR-Plug) for Repair of Knee Osteochondral Defects Phase 3
Suspended NCT00696319 - Dynamic Stability of the Anterior Cruciate Ligament (ACL) Deficient Knee N/A
Completed NCT02052856 - Anterior Cruciate Ligament (ACL) Tunnel Widening Comparing All-inside and Interference Screw Fixation Technique N/A
Completed NCT00821873 - Evaluation of the CR Plug for Repair of Defects Created at the Harvest Site From an Autograft in the Knee. Phase 3
Completed NCT01950208 - The Munich Knee Questionnaire - Development and Validation N/A
Completed NCT00894595 - Preventing Knee Injuries in Adolescent Female Football Players N/A
Recruiting NCT02636881 - Autologous Cartilage Implantation vs Arthroscopic Debridement N/A